10x Genomics (TXG) Non Operating Interest Expenses (2018 - 2025)

10x Genomics has disclosed Non Operating Interest Expenses across 8 years of filings, most recently posting -$3000.0 for Q3 2025.

• In Q3 2025, Non Operating Interest Expenses fell 250.0% year-over-year to -$3000.0; the TTM figure through Jun 2025 stood at $5000.0 (down 54.55% YoY), while the FY2024 annual figure was $4000.0, down 87.88% from the prior year.
• Non Operating Interest Expenses came in at -$3000.0 for Q3 2025 at 10x Genomics, down from $3000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $221000.0 in Q1 2021 to a low of -$3000.0 in Q3 2025.
• Average Non Operating Interest Expenses over 5 years is $81117.6, with a median of $19000.0 recorded in 2023.
• The largest YoY upside for Non Operating Interest Expenses was 200.0% in 2025 against a maximum downside of 250.0% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $217000.0 in 2021, then plunged by 42.4% to $125000.0 in 2022, then sank by 93.6% to $8000.0 in 2023, then plunged by 75.0% to $2000.0 in 2024, then sank by 250.0% to -$3000.0 in 2025.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$3000.0 in Q3 2025, $3000.0 in Q2 2025, and $2000.0 in Q3 2024.